Brilticar 60 contains Ticagrelor (60 mg) an antiplatelet agent used to reduce the risk of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. Ticagrelor inhibits platelet activation and aggregation preventing the formation of blood clots that can lead to heart attacks or strokes. Often used in conjunction with aspirin Brilticar enhances overall cardiovascular protection and improves patient outcomes.
Reviews
There are no reviews yet.